Based on current research evidence, we hypothesize that TSG-6 encapsulated within MSCs-Exo mitigates Caspase-1-mediated GSDMD cleavage and pyroptosis by interfering with NLRP3 inflammasome activation—a critical pathogenic mechanism underlying IBD. Here, TNFAIP6 is linked to inflammatory bowel disease.